Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareCloud (CCLD) Gains from Sales and Divestitures (2016 - 2025)

CareCloud (CCLD) has disclosed Gains from Sales and Divestitures for 11 consecutive years, with $164700.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 1076.43% to $164700.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $164700.0, a 1076.43% increase, with the full-year FY2024 number at $60000.0, down 29.63% from a year prior.
  • Gains from Sales and Divestitures was $164700.0 for Q3 2025 at CareCloud, up from $89700.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $475120.0 in Q3 2021 to a low of $10000.0 in Q3 2022.
  • A 5-year average of $115121.7 and a median of $66263.0 in 2023 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: tumbled 97.9% in 2022, then skyrocketed 1076.43% in 2025.
  • CareCloud's Gains from Sales and Divestitures stood at $60010.0 in 2021, then crashed by 67.44% to $19538.0 in 2022, then soared by 336.4% to $85263.0 in 2023, then fell by 29.63% to $60000.0 in 2024, then soared by 174.5% to $164700.0 in 2025.
  • Per Business Quant, the three most recent readings for CCLD's Gains from Sales and Divestitures are $164700.0 (Q3 2025), $89700.0 (Q2 2025), and $88300.0 (Q1 2025).